The U.S. Food and Drug Administration (FDA) recently approved a ready-to-use, room-temperature stable liquid glucagon for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes ages 2 years and above. Xeris Pharmaceuticals is marketing this new glucagon injection as GVOKE. GVOKE is the first glucagon product approved that can be administered via...
Read MoreSpringtime in Washington, D.C., always includes cherry blossoms; bus loads of tourists visiting the national monuments, memorials, and museums; and groups who come to Capitol Hill to advocate on issues Congress is considering. The Endocrine Society is no exception.
Read MoreEndocrine Today | Research during the past few years has suggested that American girls are entering puberty earlier - some as young as 6 years of age. The phenomenon has been linked to specific pathologies, obesity and even environmental toxins. Fortunately, this problem has limited scope and there are ways to help children in early puberty.
Read More
